Health leaders host forums on pediatric COVID vaccine

Sonoma Valley Hospital and Sonoma Valley Community Health Center will host two virtual information forums for patents, guardians and teachers who want to learn more about the Pfizer COVID-19 pediatric vaccine that will soon be offered to young people aged 5-11. The forums provide the latest information available from the Centers for Disease Control and Food and Drug Administration and answer questions from the public. One will be in English, the other in Spanish (the English language forum will be simulcast in Spanish, while the Spanish forum will be simulcast in English).

The English-speaking panel will be led by Dr. Sabrina Kidd, chief medical officer of Sonoma Valley Hospital, who will give a brief presentation on the history of vaccine technical development and review the most recent CDC information. dr. Kidd will be joined by Cheryl Johnson, CEO of Sonoma Valley Community Health Center, who will provide an overview of the rollout plan for all eligible children in Sonoma Valley who wish to be vaccinated. Immediately after the presentation there will be an open question-and-answer session with the speakers together with Dr. Jerome Smith, a pediatrician at MarinHealth and Sonoma Valley Community Health Center; and dr. Kiana Guerrero-McCormick, who practices family medicine at the Sonoma Valley Community Health Center. (The Spanish-speaking panel will include all speakers except Dr. Kidd, who will, however, be available to answer questions through an interpreter.)

The first Zoom forum, scheduled for Thursday, October 28, 6-7pm, will be in English with Spanish simulcast (the webinar ID is: 977 1690 7322). The next one is scheduled for Wednesday, November 3rd, from 6:00 PM to 7:00 PM in Spanish with English simulcast (the webinar ID is: 940 7044 3800).

The forum is aimed at local parents and families.

Audience participants are encouraged to send inquiries in advance to Sonoma Valley Hospital by email at or to Find the Zoom link at, under COVID-19 updates.

Comments are closed.